The global synoptophore market size is expected to reach USD 358.4 million by 2030, registering a CAGR of 6.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The key factors such as increasing prevalence of visual acuity disorders such as amblyopia, strabismus, diplopia, and other convergence insufficiency ailments are expected to drive the market.
Increasing the prevalence of risk factors leading to amblyopia and strabismus is expected to drive the demand for synoptophore machines in the extended run. For instance, there are multiple risk factors causing amblyopia that includes strabismus, uncorrected refractive errors, premature birth, cataract, ptosis, traumatic head injury, and hereditary factors.
The growing awareness about the importance of early diagnosis to avoid surgical intervention in the future will increase the utilization rate of synoptophore. Moreover, the increasing inclination towards non-surgical treatment procedures is expected to propel the growth of the market.
The reliability, versatility, and accuracy of synoptophore in performing comprehensive binocular vision assessments in patient with ocular motility disorders have increased its installation rate. However, high cost, lack of portability, and the difficultly in setting up the pediatric patient for diagnosis are the factors restraining the growth of the market.
Request a free sample copy or view report summary: Synoptophore Market Report
The manual segment dominated the market with a revenue share of 56.5% in 2024, driven by its cost-effectiveness and widespread availability. Manual synoptophores are often preferred due to their lower maintenance costs and ease of use, making them suitable for various healthcare settings, especially in developing regions.
The diagnostic segment dominated the market, with the largest revenue share in 2024, which can be attributed to its critical role in identifying visual disorders. Synoptophores are widely used for comprehensive assessments of ocular muscle imbalances and binocular vision issues, making them indispensable tools in ophthalmology.
The Hospitals segment dominated the market with the largest revenue share in 2024, driven by the high volume of patients requiring eye care services.
North America synoptophore market dominated the global market with a revenue share of 25.9% in 2024, driven by a combination of advanced healthcare infrastructure and high prevalence rates of visual disorders.
Grand View Research has segmented global synoptophore market report based on type, application, end-use, and region:
Synoptophore Type Outlook (Revenue, USD Million, 2018 - 2030)
Manual
Automated
Synoptophore Application Outlook (Revenue, USD Million, 2018 - 2030)
Diagnostic
Therapeutic
Synoptophore End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Clinics
Others
Synoptophore Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Norway
Denmark
Sweden
Asia Pacific
Japan
China
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Synoptophore Market
Prkamya Visions
66 Vision Tech Co., Ltd.
cnlink-group.com
Nanjing Redsun Optical Co., Ltd.
Gem Optical Instruments Industries
haag-streit.com
Takagi Seiko Co., Ltd.
Appasamy Associates Private Limited
Rumax International Private Limited
DAHLGREN INDIA PRIVATE LIMITED
"The quality of research they have done for us has been excellent..."